Product Information

BRIMONIDINE-TIMOLOL 0.2%-0.5% is a generic product labeled by Apotex Corp., priced at $2.4609 per ML under NDC 60505058902. Its NADAC has been published 194 times since Dec 7, 2022.

FDA first approved this application on Apr 20, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BRIMONIDINE-TIMOLOL 0.2%-0.5%

Brimonidine Tartrate and Timolol Maleate
$2.4609per ML

Strength

2; 5 mg/mL; mg/mL

Manufacturer

Apotex Corp.

NDC

60505058902

Classification

Generic

Dosage Form

SOLUTION

Route

OPHTHALMIC

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA091442

FDA Approved

4/20/2022

TE Code

AB

On Market Since

10/19/2022

Pharmacological Classes

Adrenergic alpha-Agonists
Adrenergic beta-Antagonists
alpha-Adrenergic Agonist
beta-Adrenergic Blocker

Price Statistics

The NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has been published 194 times since Dec 7, 2022, and over the history we have for it it has declined 92.4%. The table below summarizes its recorded NADAC range and movement.

Current price$2.4609 per ML
All-time high$32.3339 (Dec 14, 2022)
All-time low$2.3704 (May 20, 2026)
52-week high$4.6326
52-week low$2.3704
Median price$9.4084
Average price$10.7500
Largest weekly change+56.9% (May 22, 2024)
Weeks tracked194
Tracking sinceDec 7, 2022

Price History

1W

-8.0%

1M

-8.0%

3M

+3.8%

6M

-11.4%

1Y

-46.9%

3Y

-85.9%

5Y

N/A

All

-92.4%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 25% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BRIMONIDINE-TIMOLOL 0.2%-0.5%?

The current National Average Drug Acquisition Cost (NADAC) for BRIMONIDINE-TIMOLOL 0.2%-0.5%, manufactured by Apotex Corp., is $2.4609 per ML (NDC 60505058902), effective Aug 19, 2026.

How has the price of BRIMONIDINE-TIMOLOL 0.2%-0.5% changed over time?

Over the history we have for it, the NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has declined 92.4%. It has been tracked across 194 weekly CMS publications since Dec 7, 2022.

What are the highest and lowest recorded NADAC prices for BRIMONIDINE-TIMOLOL 0.2%-0.5%?

Since Dec 7, 2022, the NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has ranged from a low of $2.3704 (May 20, 2026) to a high of $32.3339 (Dec 14, 2022), with a median of $9.4084 per ML.

Are there cheaper alternatives to BRIMONIDINE-TIMOLOL 0.2%-0.5%?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BRIMONIDINE-TIMOLOL 0.2%-0.5%, is $1.8390 per ML — about 25% below BRIMONIDINE-TIMOLOL 0.2%-0.5%.

Who manufactures BRIMONIDINE-TIMOLOL 0.2%-0.5%?

BRIMONIDINE-TIMOLOL 0.2%-0.5% (NDC 60505058902) is labeled by Apotex Corp., and CMS classifies it as a generic product.